BACKGROUND Transgender individuals' cancer prevalence and transgender cancer survivors' health needs have received scarce attention. The current study compared transgender and cisgender individuals' cancer prevalence and described the health needs of transgender cancer survivors. METHODS The authors used Behavioral Risk Factor Surveillance System data on 95,800 cisgender and transgender individuals who self-reported a cancer diagnosis. Using multiple logistic regression, they estimated cancer prevalence and calculated odds ratios with 95% confidence intervals of physical, psychological, overall health, and health behaviors of transgender survivors compared with cisgender survivors. RESULTS After adjusting for confounders, transgender men had a significantly higher (>2-fold) number of cancer diagnoses compared with cisgender men, but not cisgender women. Cancer prevalence among gender nonconforming individuals and transgender women was not significantly different from that of cisgender men and cisgender women. Gender nonconforming survivors had significantly greater physical inactivity, heavy episodic alcohol use, and depression compared with cisgender men and cisgender women. Transgender men survivors were significantly more likely to report poor physical health and greater medical comorbidities and were less likely to report smoking compared with cisgender men and cisgender women. Transgender women survivors were significantly more likely to report diabetes compared with cisgender men and cisgender women and were more likely to report cardiovascular disease compared with cisgender women. CONCLUSIONS Clinicians should be aware of the higher prevalence of cancer among transgender men and a potential survivorship bias among transgender individuals. Transgender survivors have considerable variation in their risk profile. Clinicians and health services can target gender nonconforming survivors' depression and health behaviors to improve survival and should address the complex comorbidities of transgender men and transgender women.

中文翻译：

---

跨性别者的癌症生存率：一项横断面研究的结果。

背景技术跨性别个体的癌症患病率和跨性别癌症幸存者的健康需求很少受到关注。当前的研究比较了跨性别和顺性别个体的癌症患病率，并描述了跨性别癌症幸存者的健康需求。方法作者使用了“行为风险因素监测系统”数据，对95,800名自我报告癌症诊断的顺性别和跨性别个体进行了研究。他们使用多元logistic回归估算了癌症患病率，并以95％的置信区间（与跨性别幸存者相比，跨性别幸存者的身体，心理，整体健康状况和健康行为）估算了癌症发生率。结果在校正混杂因素后，跨性别男性的癌症诊断人数比顺性别男性高得多（> 2倍），但没有顺势女性。性别不合格个体和变性女性中的癌症患病率与顺性别男性和顺性别女性没有明显差异。与顺性别男性和顺性别女性相比，性别不相符的幸存者的体育活动不活跃，大量饮酒和抑郁症明显增多。与顺性别男性和顺性别女性相比，跨性别男性幸存者报告身体健康状况和医疗合并症的可能性更高，报告吸烟的可能性也更低。与顺性别男性和顺性别女性相比，变性女性幸存者报告糖尿病的可能性明显更高，与顺性别女性相比，变性女性幸存者报告心血管疾病的可能性更高。结论临床医生应意识到跨性别男性中癌症的患病率较高，以及跨性别个体中潜在的生存偏见。跨性别幸存者的风险状况差异很大。临床医生和卫生服务机构可以针对性别不相符的幸存者的抑郁和健康行为，以提高其生存率，并应应对变性人和变性人的复杂合并症。